搜索筛选:
搜索耗时0.1107秒,为你在为你在102,285,761篇论文里面共找到 8 篇相符的论文内容
类      型:
[期刊论文] 作者:Tian-qing CHU,Rong LI,Min-hua SHAO,Jun-yi YE,Bao-hui HAN, 来源:中国药理学报(英文版) 年份:2016
[期刊论文] 作者:Bo JIN,Yu DONG,Hui-min WANG,Jin-su HUANG,Bao-hui HAN, 来源:中国药理学报(英文版) 年份:2014
[会议论文] 作者:Jia-tao Lou,Xiao-qian Wang,Xiao-hui Liang,Xue Jian,Bao-hui Han, 来源:中国医院协会临床检验管理专业委员会第七届全国临床检验实验室管理学术会议暨中华医学会第十次全国检验医学学术会议(2013N 年份:2013
[期刊论文] 作者:Bo Yan,Wei Zhang,Fang Lu,Zhong-Lin Chen,Bao-Hui Han,Li-Yan Jiang,, 来源:Asian Pacific Journal of Tropical Medicine 年份:2013
Objective:To investigate resistance and safety of HHPG-19K in treating non-small cell lung cancer patients.Methods:A total of 30 cases were selected and randoml...
[期刊论文] 作者:Bo Yan,Wei Zhang,Fang Lu,Zhong-Lin Chen,Bao-Hui Han,Li-Yan Jiang, 来源:亚太热带医药杂志(英文版) 年份:2013
Objective:To investigate resistance and safety ofHHPG-19K in treating non-small cell lung cancer patients.Methods:A total of30 cases were selected and randomly...
[期刊论文] 作者:Wei-feng MAO,Min-hua SHAO,Pin-ting GAO,Ji MA,Hui-juan LI,Gai-ling LI,Bao-hui HAN,Chong-gang YUAN, 来源:中国药理学报(英文版) 年份:2012
[期刊论文] 作者:Yi-ming Zhao,Sheng Tan,Shu-yuan Wang,Bo Zhang,Wei Nie,Yu Dong,Hua Zhong,Wei Zhang,Xiao-dong Zhao,Bao-hui Han, 来源:中国药理学报(英文版) 年份:2020
Anlotinib,a multitarget tyrosine kinase inhibitor,is effective as a third-line treatment against non-small cell lung cancer (NSCLC).However,acquired resistance...
[期刊论文] 作者:Qian,Le-le Zhang,Fang Hu,Chang-hui Li,Shu-hui Cao,Jing-wen Li,Yue Wang,Xue-yan Zhang,Mi-die Xu,Bao-hui Han, 来源:中国药理学报(英文版) 年份:2022
Long noncoding RNAs(IncRNAs)are involved in a variety of cancers,but the role of LncRNA DUBR in lung adenocarcinoma(LUAD),the most prevalent form of lung cancer,remains unclear.In this study we investigated the expression of DUBR in LUAD to......
相关搜索: